Yorktown Management & Research Company’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,300
Closed -$441K 231
2025
Q1
$441K Hold
10,300
0.48% 82
2024
Q4
$417K Hold
10,300
0.4% 112
2024
Q3
$395K Hold
10,300
0.4% 119
2024
Q2
$483K Hold
10,300
0.52% 70
2024
Q1
$535K Hold
10,300
0.51% 56
2023
Q4
$452K Sell
10,300
-6,200
-38% -$283K 0.47% 76
2023
Q3
$785K Hold
16,500
0.88% 13
2023
Q2
$628K Buy
16,500
+7,900
+92% +$286K 0.68% 41
2023
Q1
$310K Buy
+8,600
New +$379K 0.33% 130

Other funds holding OVV

Yorktown Management & Research Company's OVV Position: Q2 2025 in Review

Yorktown Management & Research Company sold out of Ovintiv (OVV) in Q2 2025, closing a stake of 10,300 shares — an estimated $441K sold.

Yorktown Management & Research Company first reported a position in OVV in Q1 2023 and held it in 9 quarters. The position peaked at $785K in Q3 2023. 534 funds tracked by Wall St. Rank hold OVV as of Q2 2025.

  • Yorktown Management & Research Company reported no remaining Ovintiv position as of Q2 2025 after selling out during the quarter.
  • Yorktown Management & Research Company sold 10,300 Ovintiv shares in Q2 2025, an estimated $441K.
  • Yorktown Management & Research Company first reported a position in Ovintiv in Q1 2023 and held it in 9 quarters.
  • Yorktown Management & Research Company's Ovintiv position peaked at $785K in Q3 2023.
  • 534 funds tracked by Wall St. Rank held Ovintiv as of Q2 2025.

Based on Yorktown Management & Research Company's 13F filing for Q2 2025, filed 4 Aug 2025.